Provided by Tiger Trade Technology Pte. Ltd.

Benitec Biopharma

11.29
+0.24002.17%
Volume:46.74K
Turnover:525.36K
Market Cap:393.83M
PE:-10.20
High:11.45
Open:11.09
Low:11.01
Close:11.05
52wk High:16.76
52wk Low:9.85
Shares:34.88M
Float Shares:18.45M
Volume Ratio:0.73
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1074
EPS(LYR):-0.9800
ROE:-33.21%
ROA:-22.67%
PB:2.22
PE(LYR):-11.52

Loading ...

Jan 23, 2023

Major Issues Report

8-K - Current report
Dec 15, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 13, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 12, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2022

Major Issues Report

8-K - Current report
Oct 18, 2022

Major Issues Report

8-K - Current report
Oct 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 07, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 23, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 16, 2022

Major Issues Report

8-K - Current report
Sep 12, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 09, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 07, 2022

Major Issues Report

8-K - Current report
Sep 02, 2022

Major Issues Report

8-K - Current report
Sep 02, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 11, 2022

Correspondence

CORRESP [Cover] - Correspondence